Such favorable PK have also been seen for the GnRHR-targeting PC discussed above (11) as well as in the case of PCs targeting the vasopressin V2 receptor for the treatment of nephrogenic diabetes insipidus in humans (12). This evidence concerns the gene GNRHR and nephrogenic diabetes insipidus.